title: [Leptin: a parameter for metabolic changes in heart failure].
abstract: OBJECTIVE
  Advanced chronic heart failure is a hypercatabolic state with an imbalance between anabolic and catabolic metabolism and finally progressive loss of both muscle mass and adipose tissue. Leptin, the product of the obesity gene, is a hormone secreted by adipocytes. Therefore, we tested the hypothesis that plasma leptin concentrations are reduced in advanced chronic heart failure.
  
  
  METHODS
  In 20 patients with chronic congestive heart failure (LVEF 23 +/- 6%) and 20 healthy controls (LVEF 65 +/- 8%) matched for gender, age, and body mass index, fasting plasma leptin (ELISA) and TNF alpha (ELISA) were measured. Follow-up examination was performed after 1 year.
  
  
  RESULTS
  The fasting plasma leptin concentrations of patients with NYHA grade III (8.4 +/- 3.8 ng/ml*) and NYHA grade IV (4.6 +/- 2.4 ng/ml dagger) were significantly lower as compared with the controls (11.2 +/- 3.1 ng/ml; *p < 0.05, dagger p < 0.01). In patients with NYHA grade II plasma leptin levels were significantly elevated as compared with the healthy controls (14.9 +/- 4.2 ng/ml). TNF alpha was higher in heart failure patients than in healthy controls (8.6 +/- 3.6 pg/ml; 5.9 +/- 2.1 pg/ml; respectively; p < 0.05), but did not correlate with the NYHA functional class. Mortality of the controls was 0%, whereas 15% (n = 3) in the congestive heart failure group; one patient (5%) needs an urgent heart transplantation. All of those patients had leptin concentrations below 5 ng/ml.
  
  
  CONCLUSIONS
  Plasma leptin concentrations correlate with the NYHA functional class suggesting anabolic metabolism in NYHA class II and catabolic metabolism in advanced heart failure which might be of prognostic relevance.
authors.affiliation: Friedrich-Schiller-Universität Jena Klinik für Innere Medizin III Kardiologie, Angiologie & Internistische Intensivmedizin Erlanger Allee 101 07740 Jena, Germany. barbara.richartz@med.uni-jena-de
authors.forename: B M
authors.initials: BM
authors.lastname: Richartz
authors.forename: U
authors.initials: U
authors.lastname: Lotze
authors.forename: A
authors.initials: A
authors.lastname: Krack
authors.forename: A
authors.initials: A
authors.lastname: Gastmann
authors.forename: F
authors.initials: F
authors.lastname: Küthe
authors.forename: H R
authors.initials: HR
authors.lastname: Figulla
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002908:Chronic Disease; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D020738:Leptin / Q000097:blood*; D008297:Male; D016555:Matched-Pair Analysis; D008875:Middle Aged; D011379:Prognosis; D012016:Reference Values; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D020738:Leptin; D014409:Tumor Necrosis Factor-alpha